Bradford Perez is an Oncology physician affiliated with Florida Cancer Specialists & Research Institute. OpenAlex indexes 136 publications with 2,147 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9320 State Road 54
Trinity, FL 346551808
Telephone
727-842-8411Provider last certified this registry record 30 Nov 2023.
Clinical trials
- Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20259 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20254 payments
- Merck Sharp & Dohme LLCProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
28.6%Opioid Agonist20.8%Oxycodone Hcl100%Part D≥25 patientsBenzodiazepine7.7%Lorazepam100%Part D<11 patientsGenitourinary & hormones
22.6%alpha-Adrenergic Blocker22.6%Tamsulosin Hcl100%Part D≥16 patientsDermatology
17.9%Corticosteroid10.7%Methylprednisolone100%Part D≥17 patientsPolyene Antifungal7.1%Nystatin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2019–2023 per NIH RePORTER. The latest:
- Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
H. Lee Moffitt Cancer Ctr & Res Inst
FY2023$238,752K08CA231454 - Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
H. Lee Moffitt Cancer Ctr & Res Inst
FY2022$238,752K08CA231454 - Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
H. Lee Moffitt Cancer Ctr & Res Inst
FY2021$238,752K08CA231454
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion
Journal for ImmunoTherapy of Cancer
2025 - Technical feasibility of novel immunostimulatory low‐dose radiation for polymetastatic disease with CBCT‐based online adaptive and conventional approaches
Journal of Applied Clinical Medical Physics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
Satish Shanbhag, MD, MPH
Florida Cancer Specialists & Research Institute
Ivor Percent, MD
Florida Cancer Specialists & Research Institute
Scott Lunin, MD
Florida Cancer Specialists & Research Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”